SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

RGEN Repligen Corp: if deal terminated under some circumstances, Biolife may be required to pay Repligen a termination fee of $59M

RGEN

This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.